Interventionalists treating patients suffering from Peripheral Vascular Disease (PVD) in the Superficial Femoral Artery (SFA) require a flexible stent-graft capable of re-lining tortuous arteries.
The GORE® VIABAHN® Endoprosthesis is constructed with a durable, reinforced, biocompatible, expanded polytetrafluoroethylene (ePTFE) liner attached to an external nitinol stent structure. The extreme flexibility of the GORE® VIABAHN® Endoprosthesis enables it to better traverse tortuous areas of the SFA and conform more closely to the complex anatomy of the artery. W. L. Gore & Associates has now added a heparin-bonded surface to the GORE® VIABAHN® Endoprosthesis.
The GORE® VIABAHN® Endoprosthesis with PROPATEN Bioactive Surface is approved for endovascular grafting of the peripheral arteries. The latest interventional product offering from W. L. Gore & Associates, the stent-graft features the addition of proprietary heparin-bonded technology to the proven combination of ePTFE and nitinol. End-point covalent bonding keeps heparin anchored to the endoprosthesis surface while the bioactive site remains free to interact with the blood.
With a new lower-profile, streamlined delivery system, the GORE® VIABAHN® Endoprosthesis with PROPATEN Bioactive Surface makes it easier to reach and treat challenging SFA lesions.